Immune persistence and response to booster dose of Vi-DT vaccine at 27.5 months post-first dose

Vaccination with typhoid conjugate vaccines (TCV) is a major part of typhoid prevention. However, little is known about long-term immune persistence following vaccination with TCVs. In this phase-2, randomized double-blind trial (NCT03527355), 285 children aged 6–23 months were randomized to one of...

Descripción completa

Detalles Bibliográficos
Autores principales: Capeding, Maria Rosario, Tadesse, Birkneh Tilahun, Sil, Arijit, Alberto, Edison, Kim, Deok Ryun, Park, Eun Lyeong, Park, Ju Yeon, Yang, Jae Seung, Eluru, Jagadeesh Reddy, Jo, Sue-Kyoung, Kim, Hun, Yang, Seon-Young, Ryu, Ji Hwa, Park, Hokeun, Shin, Jong Hoon, Lee, Yoonyeong, Kim, Jerome H., Mojares, Zenaida Reynoso, Wartel, T. Anh, Sahastrabuddhe, Sushant
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8795159/
https://www.ncbi.nlm.nih.gov/pubmed/35087084
http://dx.doi.org/10.1038/s41541-022-00434-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8795159/
https://www.ncbi.nlm.nih.gov/pubmed/35087084
http://dx.doi.org/10.1038/s41541-022-00434-8

Ejemplares similares